The Patent Finder
AP

Apellis Pharmaceuticals, Inc.

First filing 2004
OverviewNotableFeesChangesFamiliesPatent listSources & methods

27 patents currently held

2 more in force are now held by other companies
Held is read from USPTO's recorded assignments; a transfer never recorded there does not appear.

The next term ends in Apr 2027. from the record

Free plan: 3 watched companies. Pro: unlimited.
Alerts on its grants, lapses and transfers.
2
Ending by 2030
Apr 2027
Next term end
14
Patent families

When these terms end

Held patents by the year their term ends
20262027202820292030203120322033203420352036203720382039204020412042204320442045
notable patents fee due within 90 days all others Updated Nov 16, 2026 · includes USPTO assignment & status data published Nov 16, 2026 and grant & fee data published Nov 10, 2026 (weekly) · how we know
Notable: the highest-ranked patents in this portfolio by citations and family size. Fee due within 90 days: a maintenance fee is due within 90 days of when this page was computed and not yet paid.

Fee deadlines

Maintenance fees fall due 3.5, 7.5 and 11.5 years after grant. A missed fee ends a patent at the end of the six month grace period that follows, not on the due date.
  • 1 fee due Nov 30, 2026
    The maintenance fee for Cell-Reactive, Long-Acting, or Targeted Compstatin Analogs and Uses Thereof (US 11,661,441) comes due Nov 30, 2026. Unpaid by Jun 1, 2027, it lapses early.
  • 1 fee due Dec 4, 2026
    The maintenance fee for Cell-Penetrating Compstatin Analogs and Uses Thereof (US 10,308,687) comes due Dec 4, 2026. Unpaid by Jun 4, 2027, it lapses early.
  • 1 fee due Feb 1, 2027
    The maintenance fee for Methods of Treating Chronic Disorders with Complement Inhibitors (US 11,712,460) comes due Feb 1, 2027. Unpaid by Aug 2, 2027, it lapses early.
  • 1 fee due Jun 19, 2027
    The maintenance fee for Dosing Regimens and Related Compositions and Methods (US 11,844,841) comes due Jun 19, 2027. Unpaid by Dec 20, 2027, it lapses early.
  • 1 fee due Aug 20, 2027
    The maintenance fee for Dosing Regimens (US 11,903,994) comes due Aug 20, 2027. Unpaid by Feb 22, 2028, it lapses early.

Which patents, and when each one lapses · Pro

Recent changes

  • 1 of the patents on this record was granted since Aug 18, 2026
  • 2 terms have ended since Aug 18, 2026

What they patent

The 5 largest of its 14 families, grouped by real patent family and labeled by the earliest filing in each. No technology classification is inferred from titles.

Patents held now

Soonest term end first.
PatentTitleStatusExpiresConfidence
US 8,168,584Methods of Treating Age-Related Macular Degeneration by Compstatin and Analogs Thereof
In force
 · High confidence
In forceHigh confidence
US 8,580,735Local Complement Inhibition for Treatment of Complement-Mediated Disorders
In force
 · High confidence
In forceHigh confidence
US 10,696,718Compstatin Analogs for Treatment of Neuropathic Pain
In force
 · High confidence
In forceHigh confidence
US 11,001,610Cell-Reactive, Long-Acting, or Targeted Compstatin Analogs and Uses Thereof
In force
 · High confidence
In forceHigh confidence
US 9,421,240Compstatin Analogs for Treatment of Neuropathic Pain
In force
 · High confidence
In forceHigh confidence
US 11,013,782Methods of Treating Chronic Disorders with Complement Inhibitors
In force
 · High confidence
In forceHigh confidence
US 11,712,460Methods of Treating Chronic Disorders with Complement Inhibitors
In force
 · High confidence
In forceHigh confidence
US 11,661,441Cell-Reactive, Long-Acting, or Targeted Compstatin Analogs and Uses Thereof
In force
 · High confidence
In forceHigh confidence
US 10,125,171Cell-Reactive, Long-Acting, or Targeted Compstatin Analogs and Uses Thereof
In force
 · High confidence
In forceHigh confidence
US 11,291,407Detection of High Risk Drusen
In force
 · High confidence
In forceHigh confidence
10 of 27 patents shown.
Pro members see all 27.
Pro members: see all 27 patents
Also on record, not counted in the 27: 2 patents in force now held by others · 4 patents ended · 25 applications pending · 34 applications abandoned. List them

Sources and methods

Compiled from USPTO application file histories, grants and recorded assignments, with the company's own names reviewed by hand. How this record was built
Portfolio grouped automatically from ownership conveyances to the names matched to this company, usually every name that begins with its own, so it counts patents an affiliate holds; each list row names the holder of record. Security interests are excluded and ambiguous records are not reviewed by hand.
Fee due within 90 days marks a patent with a maintenance fee due within 90 days of the date this page was computed and not yet recorded paid, so it can end earlier than the bar shows. A fee left unpaid ends the patent at the close of the six month grace period that follows its due date, not on the due date itself. It is not a prediction that the fee will be missed.
Computed patent terms end on the dates shown. Related patents and pending applications may cover overlapping subject matter.
The Patent Finder CompaniesExpirationsCalculatorWatchlistPricing MethodologyCorrectionsLegalPrivacysupport@thepatentfinder.com Updated Nov 16, 2026 · includes USPTO assignment & status data published Nov 16, 2026 and grant & fee data published Nov 10, 2026 (weekly) Part of 137 Finder · © 2026 137 Finder LLC · Sources cited